Alan Menter
Impact in
- Dermatology top 0.01%
- Dermatology and Skin Diseases
- Immunology top 0.02%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Immunology 277
- Psoriasis: Treatment and Pathogenesis 260
- Dermatology 110
- Dermatology and Skin Diseases 83
- Co-authors
- Mark Lebwohl (45 shared papers)Alice B. Gottlieb (37 shared papers)Steven R. Feldman (28 shared papers)John Koo (23 shared papers)Kenneth B. Gordon (25 shared papers)Kim Papp (35 shared papers)Craig L. Leonardi (24 shared papers)James G. Krueger (15 shared papers)
- Journals
- Journal of the American Academy of Dermatology (89 papers)British Journal of Dermatology (30 papers)Dermatology and Therapy (17 papers)Journal of the European Academy of Dermatology and Venereology (15 papers)Journal of Dermatological Treatment (9 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Alan Menter
379 papers receiving 24.7k citations
Alan Menter's Hit Papers
Peers
Comparison fields: 5 of 150
- Dermatology 8.0k
- Immunology 17.7k
- Rheumatology 3.8k
- Hematology 1.8k
- Complementary and Manual Therapy 318
Countries citing papers authored by Alan Menter
This map shows the geographic impact of Alan Menter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Menter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Menter more than expected).
Fields of papers citing papers by Alan Menter
This network shows the impact of papers produced by Alan Menter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Menter. The network helps show where Alan Menter may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Menter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 386 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines of care for the management of psoriasis and psoriatic arthritis Hit paper breakdown → | 2008 | 974 |
| 2 | The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Hit paper breakdown → | 2001 | 794 |
| 3 | Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis Hit paper breakdown → | 2012 | 734 |
| 4 | Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial Hit paper breakdown → | 2007 | 698 |
| 5 | Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials Hit paper breakdown → | 2015 | 664 |
| 6 | Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis Hit paper breakdown → | 2010 | 650 |
| 7 | Guidelines of care for the management of psoriasis and psoriatic arthritis Hit paper breakdown → | 2008 | 615 |
| 8 | A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci Hit paper breakdown → | 2008 | 503 |
| 9 | Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis Hit paper breakdown → | 2018 | 494 |
| 10 | 1999 | 473 | |
| 11 | 2004 | 454 | |
| 12 | Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial Hit paper breakdown → | 2009 | 447 |
| 13 | 2006 | 422 | |
| 14 | 2009 | 418 | |
| 15 | 2006 | 411 | |
| 16 | 2017 | 401 | |
| 17 | 2011 | 378 | |
| 18 | 2009 | 357 | |
| 19 | 1994 | 323 | |
| 20 | 2003 | 314 |
About Alan Menter
Alan Menter is a scholar working on Immunology, Dermatology, Pathology and Forensic Medicine, Rheumatology and Epidemiology, having authored 386 papers that have together received 25.6k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (260 papers), Dermatology and Skin Diseases (83 papers), Autoimmune Bullous Skin Diseases (43 papers), Asthma and respiratory diseases (22 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical studies and practices (19 papers), Spondyloarthritis Studies and Treatments (18 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). The work is most often cited by research in Dermatology (8.0k citations), Immunology (17.7k citations), Rheumatology (3.8k citations), Hematology (1.8k citations) and Complementary and Manual Therapy (318 citations). Alan Menter has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Mark Lebwohl, Alice B. Gottlieb, Steven R. Feldman, John Koo, Kenneth B. Gordon, Kim Papp, Craig L. Leonardi, James G. Krueger, Bruce Strober and C.E.M. Griffiths. Their work appears in journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology, Dermatology and Therapy, Journal of the European Academy of Dermatology and Venereology and Journal of Dermatological Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.